the current studies examined the potential for additive or synergistic augmentation of human natural killer ( nk ) function by combined stimulation with tumor necrosis factor alpha ( tnf-alpha ) or interleukin-1 ( il-1 ) and interferon-alpha ( ifn-alpha ) or il-2 .
C0086418
human
C0021756
il-2